Download Lip and Oral Cavity

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Lip and Oral Cavity
Anatomical subsites of the lip.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
Anatomical sites and subsites of the oral cavity.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
Anatomical sites and subsites of the oral cavity.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
Anatomical sites and subsites of the oral cavity.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
Characteristics of lip and oral cavity tumors. (a) Exophytic. (b) Ulcerated. (c)
Endophytic.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T1 is defined as tumor 2 cm or less in greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T1 is defined as tumor 2 cm or less in greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T2 is defined as tumor more than 2 cm but not more than 4 cm in
greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T2 is defined as tumor more than 2 cm but not more than 4 cm in
greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T3 is defined as tumor more than 4 cm in greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T3 is defined as tumor more than 4 cm in greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T3 is defined as tumor more than 4 cm in greatest dimension.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T4a (lip) is defined as moderately advanced local disease, tumor invading
through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face,
i.e., chin or nose (as shown).
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T4a (oral cavity) is defined as moderately advanced local disease, tumor
invading adjacent structures only (e.g., through cortical bone [mandible or
maxilla] into deep [extrinsic] muscle of tongue (genioglossus, hyoglossus,
palatoglossus, and styloglossus), maxillary sinus, or skin of face.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Lip and Oral Cavity
T4b is defined as very advanced local disease, tumor involves masticator
space, pterygoid plates (as shown), or skull base and/or encases internal
carotid artery.
Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, 2012. ©American Joint Committee on Cancer
Related documents